Clinical trials recruiting for Squamous Non-small-cell Lung Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALE.P02 | 1 |
| ALE.P03 | 1 |
| Carboplatin | 1 |
| Intismeran autogene | 1 |
| Nab-paclitaxel | 1 |
| Paclitaxel | 1 |
| Pembrolizumab | 1 |
| VLS-1488 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Connecticut | 3 |
| Illinois | 3 |
| New Jersey | 3 |
| Texas | 3 |
| Virginia | 3 |
| Arizona | 2 |
| Kentucky | 2 |
| Michigan | 2 |
| New York | 2 |
| Ohio | 2 |
| Colorado | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
- A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Related conditions
Trials recruiting for Squamous Non-small-cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Squamous Non-small-cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.